Minimal residual disease (MRD) analysis in Non-MRD based ALL ICBFM 2002 protocol for childhood ALL: Is it possible to omit minimal residual disease in risk stratification?

被引：0

作者：

Fronkova, Eva

Avigad, Smadar

Chik, Ki Wai

Castillo, Luis

Sigal, Manor

Reznickova, Leona

Zdrahalova, Katerina

Skocovska, Tatana

Schrappe, Martin

Conter, Valentino

Izraeli, Shai

Li, Chi Kong

Stark, Batia

Hrusak, Ondrej

Mejstrikova, Ester

Stary, Jan

Trka, Jan

机构：

[1] Charles Univ Prague, Sch Med 2, IL-52621 Prague, Czech Republic

[2] Schneider Childrens Med Ctr Israel, Petah Tiqwa, Israel

[3] Prince Wales Hosp, Dept Pediat, Hong Kong, Hong Kong, Peoples R China

[4] Ctr Hosp Periera Rossell, Montevideo, Uruguay

[5] Univ Hosp Schleswig Holstein, Kiel, Germany

[6] Univ Milan, Dept Pediat, Milan, Italy

[7] Chaim Sheba Med Ctr, Tel Hashomer, Israel

来源：

关键词：

D O I：

10.1182/blood.V108.11.2271.2271

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2271

引用

页码：643A / 643A

页数：1